Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.9.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
XBB.1.16.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KT.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.49.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.58.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDNEWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
LT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.54.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.30.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
LE.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.55.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used